First Trust Capital Management’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

First Trust Capital Management’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-175,036	Closed	-$5.92M	–	290
2021 Q2	$5.92M	Buy	+175,036	New	+$4.46M	0.88%	16

First Trust Capital Management's CNST Position: Q3 2021 in Review

First Trust Capital Management sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 175,036 shares — an estimated $5.92M sold.

First Trust Capital Management first reported a position in CNST in Q2 2021 and held it in 1 quarter. The position peaked at $5.92M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

First Trust Capital Management reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
First Trust Capital Management sold 175,036 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $5.92M.
First Trust Capital Management first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2021 and held it in 1 quarter.
First Trust Capital Management's Constellation Pharmaceuticals, Inc. position peaked at $5.92M in Q2 2021.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on First Trust Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.